CTX-M-producing Escherichia coli strains: resistance to temocillin, fosfomycin, nitrofurantoin and biofilm formation

Future Microbiol. 2022 Jul:17:789-802. doi: 10.2217/fmb-2021-0202. Epub 2022 May 13.

Abstract

Aim: ESBL-producing and bacterial biofilms-forming Escherichia coli are associated with antimicrobial treatment failure. This study aimed to investigate the phenotypic resistance mechanisms of CTX-M E. coli against old antibiotics - cell wall synthesis inhibitors temocillin, nitrofurantoin and fosfomycin. Materials & Methods: Susceptibility to old antibiotics testing was performed using disk diffusion method, biofilm formation was evaluated spectrophotometrically, and PCR was used for the determination of CTX-M type. Results & conclusion: Temocillin was active against nearly 93%, nitrofurantoin and fosfomycin, respectively, 91.7% and 98.6% of tested E. coli. Thus, it demonstrated to be a good alternative therapeutic option against ESBL infections. Bacteria resistant to old antibiotics had CTX-M-15 or CTX-M-15, TEM-1 and OXA-1 combinations. No significant association was found between CTX-M E. coli resistance to temocillin, nitrofurantoin and fosfomycin; however, the level of biofilm formation was found as not affected by the type of CTX-M β-lactamases.

Keywords: CTX-M β-lactamases; ESBL E. coli; biofilm formation; old antibiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Biofilms
  • Escherichia coli / genetics
  • Escherichia coli Infections* / microbiology
  • Fosfomycin* / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Nitrofurantoin / pharmacology
  • Penicillins
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Penicillins
  • temocillin
  • Fosfomycin
  • Nitrofurantoin
  • beta-Lactamases